PLx Pharma Irritated By Industry Self-Regulation Group’s Findings On Vazalore GI Comfort Claim

PLx disagrees with National Advertising Division’s recommendations following review on Bayer’s challenge of TV commercial and will appeal findings to National Advertising Review Board. NAD attorneys thank PLx’s “ voluntary participation” in SWIFT review but PLx makes clear it didn’t agree to a SWIFT process.

• Source: Alamy

PLx Pharma Inc. launched its Vazalore liquid-filled OTC aspirin formulated to improve absorption and reduce risk of stomach erosions and ulcers compared to immediate-release aspirin, after more than a decade of work. A competitor challenged advertising for Vazalore in an industry self-regulation forum within weeks of its launch.

More from Compliance

More from Policy & Regulation